The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Personalized Breast Cancer Treatment

Faculty of Medicine / Department of Clinical Sciences, Lund / Section I / Breast cancer treatment

Service point: 90

Personalized Breast Cancer Treatment's profile in Lund University Research portal

Description

Breast cancer is a heterogeneous disease with differences in clinical outcome and sensitivity to treatment. The choice of treatment after surgery (radiotherapy, antibodies, endocrine or chemo) is based on prognostic (risk of recurrence) and treatment predictive (choice of treatment) factors. About two thirds are cured after surgery, and still about 90% receive additional treatment. This means that some patients are over treated, but at the same time the treatment is lifesaving for others. It is extremely important to identify patients in need of additional treatment and, when needed, to choose the correct treatment. We are working towards new ways of looking at the information already collected and evaluated in the clinical routine but we’re also trying to identify new factors with both conventional techniques (e.g. immunohistochemistry) and new techniques (e.g. sequencing) that will help clinicians deciding what treatment or treatment combination will be best for the individual patient.

Staff

B

  • Pär-Ola Bendahl

    Research project participant

    par-ola [dot] bendahl [at] med [dot] lu [dot] se

F

N

  • Ulrik Narbe

    Research project participant

    ulrik [dot] narbe [at] med [dot] lu [dot] se

S

  • Martin Sjöström

    Research project participant

    martin [dot] sjostrom [at] med [dot] lu [dot] se